labetalol has been researched along with Hypotension in 28 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We compared the efficacy of the combination of enalaprilat/labetalol with that of enalaprilat/nicardipine to prevent emergence postcraniotomy hypertension." | 9.09 | A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. ( Broad, C; Ferri, E; Kross, RA; Leung, D; Melendez, JA; Pratila, M; Veronesi, M, 2000) |
| "The effects of induced hypotension with isoflurane and labetalol on cerebral edema formation were compared following a cryogenic brain injury in dogs." | 9.07 | Cerebral edema formation in dogs following hypotension induced with isoflurane and labetalol. ( Bendo, AA; Capuano, C; Cottrell, JE; Kozlowski, PB; Mendeszoon, MH, 1993) |
| "Only one previous study described nicardipine in comparison to labetalol during pregnancy." | 8.90 | The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine. ( de Groot, CJ; Meuleman, T; Nooij, LS; Roelofs, R; Visser, S; Vos, P, 2014) |
| "To compare the efficacy of intravenous Labetalol and intravenous Hydralazine in reduction of blood pressure in patients with severe pre-eclampsia." | 8.31 | Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women. ( Husain, S; Hussain, R; Kausar, M, 2023) |
| "Patients were eligible if they had a diagnosis of an acute stroke and were administered either CIV-labetalol or CIV-nicardipine." | 8.02 | Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine? ( El-Ghoroury, H; Hecht, JP; Sudekum, DM, 2021) |
| " Nicardipine and labetalol are commonly administered for the treatment of acute hypertension following stroke." | 7.91 | Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke. ( Desai, A; Hanni, C; Mohamed, W; Parker, D; Saber, H; Sadeghi, M; Singh, A, 2019) |
| " Persistent bradycardia and hypotension, unresponsive to epinephrine and norepinephrine, were suspected to have been exacerbated by chronic labetalol therapy for resistant arterial hypertension." | 7.81 | Use of enoximone in management of anaphylaxis complicated by labetalol use. ( Conway Morris, A; Hayhoe, S; Navapurkar, V, 2015) |
| "Initiation of an iv labetalol infusion resulted in good blood pressure control in a patient suffering from a Fisher grade 3 subarachnoid hemorrhage with an initial Glascow coma scale of 14/15 and mild hydrocephalus." | 7.73 | Case report: profound hypotension associated with labetalol therapy in a patient with cerebral aneurysms and subarachnoid hemorrhage. ( Baker, AJ; Choi, M; Hare, GM; Jivraj, S; Mazer, CD, 2006) |
| "In a model of uncontrolled hemorrhagic hypotension (UCHH) in rats, we examined whether blood loss or blood chemistry were affected by (1) deliberate, controlled hypotension induced with labetalol (L) or sodium nitroprusside (SNP) and (2) intravenous (iv) fluid therapy." | 7.70 | Labetalol-induced hypotension decreases blood loss during uncontrolled hemorrhage. ( Artru, AA; Geva, D; Gurevich, B; Gurman, G; Shapira, Y, 1998) |
| "On the 3rd day after a cesarean section, because of pre-eclampsia, blood pressure was still high, oral labetalol 100 mg with an 8-hour interval was given, followed by 50 mg i." | 7.68 | Hemodynamic collapse following labetalol administration in preeclampsia. ( Beier-Holgersen, R; Olsen, KS, 1992) |
| " During the first 60 min of bypass, hypotension (40-45 mm Hg) was observed in spite of phenylephrine 14 mg." | 7.67 | Bronchospasm and hypotension during cardiopulmonary bypass after preoperative cimetidine and labetalol therapy. ( Durant, PA; Joucken, K, 1984) |
| "Labetalol was administered at the conclusion of surgery as a 20-mg bolus over two minutes followed by 40 mg every 10 minutes until the desired BP was achieved (BP less than or equal to 10% above average preoperative BP or less than 150 mmHg, systolic) or 300 mg had been given." | 5.28 | Intravenous labetalol for the treatment of hypertension after carotid endarterectomy. ( Azad, SS; Goldberg, ME; Larijani, GE; Marr, AT; Seltzer, JL; Smullens, SN, 1989) |
| "179 patients (mean age 74 [SD 11] years; SBP 181 [SD 16] mm Hg; diastolic blood pressure [DBP] 95 [SD 13] mm Hg; median National Institutes of Health stroke scale [NIHSS] score 9 [IQR 5-16] points) were randomly assigned to receive labetolol (n=58), lisinopril (n=58), or placebo (n=63) between January, 2005, and December, 2007." | 5.14 | Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. ( Chernova, J; Ford, GA; Jagger, C; James, M; Mistri, A; Potter, JF; Robinson, TG, 2009) |
| "We compared the efficacy of the combination of enalaprilat/labetalol with that of enalaprilat/nicardipine to prevent emergence postcraniotomy hypertension." | 5.09 | A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. ( Broad, C; Ferri, E; Kross, RA; Leung, D; Melendez, JA; Pratila, M; Veronesi, M, 2000) |
| "The effects of induced hypotension with isoflurane and labetalol on cerebral edema formation were compared following a cryogenic brain injury in dogs." | 5.07 | Cerebral edema formation in dogs following hypotension induced with isoflurane and labetalol. ( Bendo, AA; Capuano, C; Cottrell, JE; Kozlowski, PB; Mendeszoon, MH, 1993) |
| "The present evidence suggests similar efficacy between nifedipine, hydralazine and labetalol in the treatment of severe hypertension in pregnancy." | 4.98 | Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials. ( Sequeira, RP; Sridharan, K, 2018) |
| "Only one previous study described nicardipine in comparison to labetalol during pregnancy." | 4.90 | The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine. ( de Groot, CJ; Meuleman, T; Nooij, LS; Roelofs, R; Visser, S; Vos, P, 2014) |
| "To compare the efficacy of intravenous Labetalol and intravenous Hydralazine in reduction of blood pressure in patients with severe pre-eclampsia." | 4.31 | Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women. ( Husain, S; Hussain, R; Kausar, M, 2023) |
| "Patients were eligible if they had a diagnosis of an acute stroke and were administered either CIV-labetalol or CIV-nicardipine." | 4.02 | Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine? ( El-Ghoroury, H; Hecht, JP; Sudekum, DM, 2021) |
| " Nicardipine and labetalol are commonly administered for the treatment of acute hypertension following stroke." | 3.91 | Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke. ( Desai, A; Hanni, C; Mohamed, W; Parker, D; Saber, H; Sadeghi, M; Singh, A, 2019) |
| " labetalol hydrochloride with doses greater than 300 mg in 24 hours observed a high rate of bradycardia and hypotension, but the study found that these events rarely caused clinically significant hemodynamic compromise and was not statistically associated with adverse events." | 3.91 | Safety of high-dose intravenous labetalol in hypertensive crisis. ( Brandt, MM; Hecht, JP; Mahmood, SM, 2019) |
| "To determine whether the incidence of hypotension or adverse fetal heart tracing (FHT) category change differed following antepartum administration of intravenous (IV) labetalol versus hydralazine." | 3.83 | Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low. ( Aghajanian, P; Greene, N; Kilpatrick, SJ; Rodriguez, M; Sharma, KJ, 2016) |
| " Persistent bradycardia and hypotension, unresponsive to epinephrine and norepinephrine, were suspected to have been exacerbated by chronic labetalol therapy for resistant arterial hypertension." | 3.81 | Use of enoximone in management of anaphylaxis complicated by labetalol use. ( Conway Morris, A; Hayhoe, S; Navapurkar, V, 2015) |
| "Initiation of an iv labetalol infusion resulted in good blood pressure control in a patient suffering from a Fisher grade 3 subarachnoid hemorrhage with an initial Glascow coma scale of 14/15 and mild hydrocephalus." | 3.73 | Case report: profound hypotension associated with labetalol therapy in a patient with cerebral aneurysms and subarachnoid hemorrhage. ( Baker, AJ; Choi, M; Hare, GM; Jivraj, S; Mazer, CD, 2006) |
| "In a model of uncontrolled hemorrhagic hypotension (UCHH) in rats, we examined whether blood loss or blood chemistry were affected by (1) deliberate, controlled hypotension induced with labetalol (L) or sodium nitroprusside (SNP) and (2) intravenous (iv) fluid therapy." | 3.70 | Labetalol-induced hypotension decreases blood loss during uncontrolled hemorrhage. ( Artru, AA; Geva, D; Gurevich, B; Gurman, G; Shapira, Y, 1998) |
| "A single 30 mg intravenous dose of labetalol given 20 minutes prior to cesarean delivery at 35 weeks of gestation for severe pregnancy-induced hypertension was associated with symptoms of beta-adrenergic blockade (hypoglycemia, bradycardia, hypotension) in preterm twins." | 3.69 | Neonatal adrenergic blockade following single dose maternal labetalol administration. ( Bhatt-Mehta, V; Donn, SM; Klarr, JM, 1994) |
| "On the 3rd day after a cesarean section, because of pre-eclampsia, blood pressure was still high, oral labetalol 100 mg with an 8-hour interval was given, followed by 50 mg i." | 3.68 | Hemodynamic collapse following labetalol administration in preeclampsia. ( Beier-Holgersen, R; Olsen, KS, 1992) |
| " During the first 60 min of bypass, hypotension (40-45 mm Hg) was observed in spite of phenylephrine 14 mg." | 3.67 | Bronchospasm and hypotension during cardiopulmonary bypass after preoperative cimetidine and labetalol therapy. ( Durant, PA; Joucken, K, 1984) |
| "Hypotension was observed in 11 patients (13." | 1.91 | Safety and efficacy of continuous intravenous labetalol for blood pressure control in neurosurgical patients. ( Duangprasert, G; Durongkaweroj, P; Noiphithak, R; Sukhor, S; Yindeedej, V, 2023) |
| "Labetalol was administered at the conclusion of surgery as a 20-mg bolus over two minutes followed by 40 mg every 10 minutes until the desired BP was achieved (BP less than or equal to 10% above average preoperative BP or less than 150 mmHg, systolic) or 300 mg had been given." | 1.28 | Intravenous labetalol for the treatment of hypertension after carotid endarterectomy. ( Azad, SS; Goldberg, ME; Larijani, GE; Marr, AT; Seltzer, JL; Smullens, SN, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (17.86) | 18.7374 |
| 1990's | 6 (21.43) | 18.2507 |
| 2000's | 6 (21.43) | 29.6817 |
| 2010's | 8 (28.57) | 24.3611 |
| 2020's | 3 (10.71) | 2.80 |
| Authors | Studies |
|---|---|
| Kausar, M | 1 |
| Husain, S | 1 |
| Hussain, R | 1 |
| Noiphithak, R | 1 |
| Duangprasert, G | 1 |
| Sukhor, S | 1 |
| Durongkaweroj, P | 1 |
| Yindeedej, V | 1 |
| El-Ghoroury, H | 1 |
| Sudekum, DM | 1 |
| Hecht, JP | 2 |
| Sridharan, K | 1 |
| Sequeira, RP | 1 |
| Singla, D | 1 |
| Parashar, A | 1 |
| Pandey, V | 1 |
| Mangla, M | 1 |
| Sadeghi, M | 1 |
| Saber, H | 1 |
| Singh, A | 1 |
| Hanni, C | 1 |
| Parker, D | 1 |
| Desai, A | 1 |
| Mohamed, W | 1 |
| Mahmood, SM | 1 |
| Brandt, MM | 1 |
| Caicedo, A | 1 |
| Thewissen, L | 1 |
| Naulaers, G | 1 |
| Lemmers, P | 1 |
| van Bel, F | 1 |
| Van Huffel, S | 1 |
| Nooij, LS | 1 |
| Visser, S | 1 |
| Meuleman, T | 1 |
| Vos, P | 1 |
| Roelofs, R | 1 |
| de Groot, CJ | 1 |
| Hayhoe, S | 1 |
| Navapurkar, V | 1 |
| Conway Morris, A | 1 |
| Sharma, KJ | 1 |
| Rodriguez, M | 1 |
| Kilpatrick, SJ | 1 |
| Greene, N | 1 |
| Aghajanian, P | 1 |
| Martin-Schild, S | 1 |
| Potter, JF | 1 |
| Robinson, TG | 1 |
| Ford, GA | 1 |
| Mistri, A | 2 |
| James, M | 2 |
| Chernova, J | 2 |
| Jagger, C | 2 |
| Potter, J | 1 |
| Brodie, F | 1 |
| Wilson, E | 1 |
| Ford, G | 1 |
| Robinson, T | 1 |
| Jivraj, S | 1 |
| Mazer, CD | 1 |
| Baker, AJ | 1 |
| Choi, M | 1 |
| Hare, GM | 1 |
| Durant, PA | 1 |
| Joucken, K | 1 |
| Klarr, JM | 1 |
| Bhatt-Mehta, V | 1 |
| Donn, SM | 1 |
| Bendo, AA | 1 |
| Kozlowski, PB | 1 |
| Capuano, C | 1 |
| Cottrell, JE | 1 |
| Mendeszoon, MH | 1 |
| Trejo Gabriel y Galán, JM | 1 |
| Gurevich, B | 1 |
| Artru, AA | 1 |
| Geva, D | 1 |
| Gurman, G | 1 |
| Shapira, Y | 1 |
| Huang, YC | 1 |
| Wu, BN | 1 |
| Lin, YT | 1 |
| Chen, SJ | 1 |
| Chiu, CC | 1 |
| Cheng, CJ | 1 |
| Chen, IJ | 1 |
| Kross, RA | 1 |
| Ferri, E | 1 |
| Leung, D | 1 |
| Pratila, M | 1 |
| Broad, C | 1 |
| Veronesi, M | 1 |
| Melendez, JA | 1 |
| Vallejo, R | 1 |
| DeSouza, G | 1 |
| Lee, J | 1 |
| Olsen, KS | 1 |
| Beier-Holgersen, R | 1 |
| Miranda, AF | 1 |
| Goldberg, ME | 1 |
| Seltzer, JL | 1 |
| Azad, SS | 1 |
| Smullens, SN | 1 |
| Marr, AT | 1 |
| Larijani, GE | 1 |
| Li, CH | 1 |
| Ying, SD | 1 |
| Liu, GM | 1 |
| Niu, SY | 1 |
| Valenta, LJ | 1 |
| Kern, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-center Randomised Controlled Trial to Explore the Ideal Individualized Anti-hypertension Strategies in Patients With Severe Stroke at Acute Stage[NCT02982655] | 500 participants (Anticipated) | Interventional | 2017-01-31 | Completed | |||
| Efficiency of Intravenous Lidocaine to Reduce Coughing and the Hemodynamic Changes Associated to Tracheal Extubation[NCT03731429] | Phase 4 | 144 participants (Anticipated) | Interventional | 2019-04-05 | Recruiting | ||
| Nicardipine Versus Esmolol for Management of Emergence Hypertension After Craniotomy[NCT01951950] | Phase 1 | 40 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01951950)
Timeframe: 1 hour postoperatively
| Intervention | participants (Number) |
|---|---|
| Nicardipine | 1 |
| Esmolol | 11 |
3 reviews available for labetalol and Hypotension
| Article | Year |
|---|---|
Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Topics: Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Headache; Humans; Hydralazine; Hy | 2018 |
The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Hypotension; Infant, Newborn; Labetalol; Nica | 2014 |
[Treatment of medical complications: hypertension/hypotension, hyperglycemia, hyperthermia, hypoxia, cardiac complications and pulmonary embolism].
Topics: Administration, Oral; Antihypertensive Agents; Arrhythmias, Cardiac; Cerebrovascular Disorders; Hear | 1995 |
5 trials available for labetalol and Hypotension
| Article | Year |
|---|---|
Comparative evaluation of dexmedetomidine and labetalol for attenuating hemodynamic stress responses during laparoscopic cholecystectomy in borderline hypertensive patients.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Blood Pressure; Bradycardia; Cholecystectomy, Laparosco | 2019 |
Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial.
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Humans; H | 2009 |
Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Cost-Benefit Analysis; Deg | 2009 |
Cerebral edema formation in dogs following hypotension induced with isoflurane and labetalol.
Topics: Animals; Brain; Brain Edema; Brain Injuries; Dogs; Hypotension; Isoflurane; Labetalol; Male | 1993 |
A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Anesth | 2000 |
A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Anesth | 2000 |
A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Anesth | 2000 |
A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Anesth | 2000 |
20 other studies available for labetalol and Hypotension
| Article | Year |
|---|---|
Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Hypotension; Lab | 2023 |
Safety and efficacy of continuous intravenous labetalol for blood pressure control in neurosurgical patients.
Topics: Blood Pressure; Bradycardia; Humans; Hypotension; Labetalol; Retrospective Studies | 2023 |
Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pre | 2021 |
Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Critical Illness; Databases, Factual; | 2019 |
Safety of high-dose intravenous labetalol in hypertensive crisis.
Topics: Administration, Intravenous; Adult; Aged; Antihypertensive Agents; Blood Pressure; Bradycardia; Dose | 2019 |
Effect of maternal use of labetalol on the cerebral autoregulation in premature infants.
Topics: Arterial Pressure; Blood Pressure; Cerebrum; Female; Gestational Age; Homeostasis; Humans; Hypotensi | 2013 |
Use of enoximone in management of anaphylaxis complicated by labetalol use.
Topics: Adult; Anaphylaxis; Antihypertensive Agents; Diagnosis, Differential; Enoximone; Female; Humans; Hyp | 2015 |
Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension, Pregnancy | 2016 |
Blood pressure in acute stroke: lower it or let the CHHIPS fall where they will.
Topics: Acute Disease; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Humans; Hypertensi | 2009 |
Case report: profound hypotension associated with labetalol therapy in a patient with cerebral aneurysms and subarachnoid hemorrhage.
Topics: Antihypertensive Agents; Bradycardia; Cardiotonic Agents; Dopamine; Epinephrine; Female; Humans; Hyp | 2006 |
Bronchospasm and hypotension during cardiopulmonary bypass after preoperative cimetidine and labetalol therapy.
Topics: Bronchial Spasm; Cardiopulmonary Bypass; Cimetidine; Drug Interactions; Humans; Hypotension; Intraop | 1984 |
Neonatal adrenergic blockade following single dose maternal labetalol administration.
Topics: Adult; Bradycardia; Diseases in Twins; Female; Fetal Blood; Humans; Hypoglycemia; Hypotension; Infan | 1994 |
Labetalol-induced hypotension decreases blood loss during uncontrolled hemorrhage.
Topics: Animals; Antihypertensive Agents; Combined Modality Therapy; Evaluation Studies as Topic; Fluid Ther | 1998 |
Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anesthesia; Animals; Aorta, Thoracic; Bradyca | 1999 |
Shy-Drager syndrome and severe unexplained intraoperative hypotension responsive to vasopressin.
Topics: Adrenergic beta-Antagonists; Aged; Hemodynamics; Humans; Hypotension; Intraoperative Complications; | 2002 |
Hemodynamic collapse following labetalol administration in preeclampsia.
Topics: Adult; Cesarean Section; Female; Humans; Hypotension; Labetalol; Pre-Eclampsia; Pregnancy; Premedica | 1992 |
Experience with hypotensive anaesthesia in a peripheral general hospital.
Topics: Adolescent; Adult; Anesthesia; Child; Female; Halothane; Hospitals, General; Humans; Hypotension; La | 1989 |
Intravenous labetalol for the treatment of hypertension after carotid endarterectomy.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Calcium Channel Blockers; Clonidine; Endarterecto | 1989 |
Hemodynamic effects of hypotension induced by verapamil or labetalol in dogs.
Topics: Animals; Dogs; Hemodynamics; Hypotension; Labetalol; Verapamil | 1988 |
Labetalol for hypertension.
Topics: Aged; Arrhythmias, Cardiac; Ethanolamines; Female; Humans; Hypertension; Hypotension; Labetalol; Mal | 1985 |